Sean D. Sullivan
The fertility of our minds to invent health care technology must now be matched by a commitment to assess and identify its appropriate use.
EducationPhD University of California (Berkeley), 1992 (Health Economics)
MS University of Texas (Austin), 1986 (Pharmacy)
BS Oregon State University, 1983 (Pharmacy)
Contact Infoemail: firstname.lastname@example.org
office: H-375, Health Sciences Building
1959 NE Pacific Street
Seattle, WA 98195-7630
campus box: 357630
Sean D. Sullivan, BScPharm, MSc, PhD, is Professor and Associate Dean for Research at the University of Washington School of Pharmacy. He holds a joint appointment as Professor of Health Services in the School of Public Health, is Director of the UW Pharmaceutical Outcomes Research and Policy Program (PORPP) and co-Director of the University of Washington Centers for Comparative and Health Systems Effectiveness (CHASE Alliance). He holds adjunct appointments in the School of Medicine, the Public Health Sciences Division at the Fred Hutchinson Cancer Research Center, and at Group Health Research Institute.
He completed his bachelor's degree in pharmacy from Oregon State University in 1983, master's degree in administrative and economic sciences from the University of Texas in 1986 and PhD in health economics and policy from the University of California-Berkeley in 1991.
Dr. Sullivan has authored more than 300 journal articles, book chapters, task force reports and organizational and governmental publications. In many of these writings, he has assessed the evidence and applications of medical technology in relation to coverage and reimbursement decisions. His research interests include technology assessment, medical decision-making and economic evaluation of medical technology. He is the past chair of the Academy of Managed Care Pharmacy executive committee on the AMCP Format for Formulary Submissions - the United States evidence-based guidelines for formulary decision-making.
Dr. Sullivan is a member of the Medicare Evidence Development and Coverage Advisory Committee. He is also on the editorial boards of Value in Health, PharmacoEconomics, European Journal of Health Economics and Core Evidence. He is a past president of the International Society for Pharmacoeconomics and Outcomes Research.
Roth JA, Cohen JT, Veenstra DL, Chen E, Jhuti GS, Neumann PJ, Sullivan SD. Development of A Cost-Effectiveness Analysis Framework for Modeling Treatment of Alzheimer's Disease And Mild Cognitive Impairment. Value Health. 2015 Nov;18(7):A698-9. doi: 10.1016/j.jval.2015.09.2608. Epub 2015 Oct 20. PMID: 26533910
Wonder M, Dunlop S, Chin G, Biggs J, Sullivan SD, Drummond M. Fda Breakthrough Medicines; Have They Caused Breakthrough Headaches for Hta Agencies? Value Health. 2015 Nov;18(7):A550. doi: 10.1016/j.jval.2015.09.1763. Epub 2015 Oct 20. PMID: 26533088
McDougall JA, Masaquel AS, Barnett B, Yoo B, Sullivan SD. A Trial-Based Economic Evaluation of Resource use and Costs in the Emilia Clinical Study. Value Health. 2015 Nov;18(7):A444-5. doi: 10.1016/j.jval.2015.09.1103. Epub 2015 Oct 20. PMID: 26532496
Chou R, Hashimoto R, Friedly J, Fu R, Bougatsos C, Dana T, Sullivan SD, Jarvik J. Epidural Corticosteroid Injections for Radiculopathy and Spinal Stenosis: A Systematic Review and Meta-analysis. Ann Intern Med. 2015 Aug 25. doi: 10.7326/M15-0934. [Epub ahead of print] PMID: 26302454